国际妇产科学杂志
國際婦產科學雜誌
국제부산과학잡지
JOURNAL OF INTERNATIONAL OBSTETRICS AND GYNECOLOGY
2014年
3期
263-266
,共4页
子宫内膜异位症%孕激素类%治疗
子宮內膜異位癥%孕激素類%治療
자궁내막이위증%잉격소류%치료
Endometriosis%Progestins%Therapy
子宫内膜异位症(endometriosis,EMs)是妇科常见、良性、慢性疾病,需长期或重复性使用药物来控制相关症状。手术是治疗EMs的常用方法,但单纯手术复发率高,术后患者常需辅助药物治疗。EMs是一种雌激素依赖性疾病,药物治疗的目的是营造低雌激素环境,抑制异位内膜的生长或使之萎缩。孕激素因具有良好的耐受性、轻微的代谢影响及相对较低的成本,成为目前术后治疗EMs唯一安全且经济的首选药物,而左炔诺孕酮宫内缓释系统特别适用于合并子宫腺肌病的EMs患者。针对个体状况的不同,孕激素治疗方案的选择不同,选择治疗方案时应考虑药物不良反应及其准确的作用机制。就孕激素治疗EMs最新分子机制的研究、常用种类、常用剂型和剂量及其应用前景等方面作一综述。
子宮內膜異位癥(endometriosis,EMs)是婦科常見、良性、慢性疾病,需長期或重複性使用藥物來控製相關癥狀。手術是治療EMs的常用方法,但單純手術複髮率高,術後患者常需輔助藥物治療。EMs是一種雌激素依賴性疾病,藥物治療的目的是營造低雌激素環境,抑製異位內膜的生長或使之萎縮。孕激素因具有良好的耐受性、輕微的代謝影響及相對較低的成本,成為目前術後治療EMs唯一安全且經濟的首選藥物,而左炔諾孕酮宮內緩釋繫統特彆適用于閤併子宮腺肌病的EMs患者。針對箇體狀況的不同,孕激素治療方案的選擇不同,選擇治療方案時應攷慮藥物不良反應及其準確的作用機製。就孕激素治療EMs最新分子機製的研究、常用種類、常用劑型和劑量及其應用前景等方麵作一綜述。
자궁내막이위증(endometriosis,EMs)시부과상견、량성、만성질병,수장기혹중복성사용약물래공제상관증상。수술시치료EMs적상용방법,단단순수술복발솔고,술후환자상수보조약물치료。EMs시일충자격소의뢰성질병,약물치료적목적시영조저자격소배경,억제이위내막적생장혹사지위축。잉격소인구유량호적내수성、경미적대사영향급상대교저적성본,성위목전술후치료EMs유일안전차경제적수선약물,이좌결낙잉동궁내완석계통특별괄용우합병자궁선기병적EMs환자。침대개체상황적불동,잉격소치료방안적선택불동,선택치료방안시응고필약물불량반응급기준학적작용궤제。취잉격소치료EMs최신분자궤제적연구、상용충류、상용제형화제량급기응용전경등방면작일종술。
Endometriosis ( EMs ) is a common , benign and chronic disease of gynecology , it requires long-term or repeated courses of medication treatment to control its related symptoms. EMs is often treated surgically but with a higher rate of recurrence,patients of postoperation often need medical adjuvant therapy. EMs is a kind of estrogen dependent disease ,the purpose of drug treatment is to creat an environment of low estrogen, inhibit the growth of ectopic endometrium or make it atrophy. Progestins have good tolerability,minor metabolic effects and low cost,there must therefore be considered drugs of choice and are currently the only safe and economic alternative to surgery, and levonorgestrel releasing intrauterine system is especially suitable for the patients who have EMs combined uterine muscle gland disease. According to the stage of individual , the choice of progestin program is different when select a therapeutic schedule drug adverse reaction and mechanism of accurate action should be considered. This article reviews the latest researches of progestins in treating EMs on molecular mechanism , commonly used types,commonly used formulations and dosage,application prospect.